H1B Report
Side-by-side comparison

Boston Medical Center Corporation vs WIPRO LIMITED

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Boston Medical Center Corporation
MARank #FEIN 04-3314093
Entity B
WIPRO LIMITED
NJRank #6FEIN 98-0154401

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricBoston Medical Center CorporationWIPRO LIMITED
Total filings41072,392
Certified %86.34%91.61%
Denied %1.95%0.37%
Withdrawn %0.98%1.37%
Cert-withdrawn %10.73%6.64%
Rank#6
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateMANJ

Outcomes — Boston Medical Center Corporation

DOL case-status mix.

Outcome breakdown: Certified 86.3%, Cert-withdrawn 10.7%, Withdrawn 1.0%, Denied 1.9%
Outcome breakdown
OutcomeShare
Certified86.3%
Cert-withdrawn10.7%
Withdrawn1.0%
Denied1.9%
Certified86.3%
Cert-withdrawn10.7%
Withdrawn1.0%
Denied1.9%

Outcomes — WIPRO LIMITED

DOL case-status mix.

Outcome breakdown: Certified 91.6%, Cert-withdrawn 6.6%, Withdrawn 1.4%, Denied 0.4%
Outcome breakdown
OutcomeShare
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%
Certified91.6%
Cert-withdrawn6.6%
Withdrawn1.4%
Denied0.4%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Boston Medical Center Corporation
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201022
FY201124
FY201221
FY201327
FY201416
FY201515
FY201623
FY201730
FY201827
FY201934
FY20200
FY20210
FY20223
FY202323
FY202449
FY202554
FY202642
WIPRO LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20103,039
FY20113,025
FY20127,031
FY20136,574
FY20148,104
FY201511,824
FY201610,254
FY20175,012
FY20186,067
FY20194,154
FY202094
FY2021128
FY202297
FY2023554
FY20242,296
FY20252,289
FY20261,850

Top 5 occupations — Boston Medical Center Corporation

Top 5 occupations — WIPRO LIMITED

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.